P 30: Cardiovascular risk factors in type 2 diabetes along 3 years of follow-up

• Published in: Diabetes & metabolism 2012-11, Vol.38, p.S115-S115
• Main Authors: Arrieta, F, Piñera, M, Nogales, P, Iglesias, R, Tutor, E, Salinero, M, Abanades, J.C, Botella, J.I, Calañas, A, Iglesias, P, Balsa, J.A, Zamarron, I, Rovira, A, Vazquez, C
• Format: Article
• Language: English
• Subjects: Endocrinology & Metabolism; Internal Medicine
• ISSN: 1262-3636
• DOI: 10.1016/S1262-3636(12)71610-5

Background & Aims The clinical evolution and cardiovascular risk factors and complications of type 2 diabetes (DM2) have not been well studied. Therefore, the aim of our study was to analyze the clinical and cardiovascular chronic complications evolution of this DM2 population in clinical practice, along three years of following, in the daily practice of primary care. We aimed to evaluate the outcomes of DM2 focusing on metabolic control and incidence of complications’. Methods From 2007 to 2010 we prospectively included 3268 patients with DM2, followed by 153 primary care physicians from 51 health centers, and an epidemiological, observational, prospective cohort study with annual cuts over 3 years to the same population being analyzed baseline data from the cross section of patients diagnosed with DM2 for measure the control of cardiovascular risk and the incidence of diabetic complication along the time. Results A decrease of glucose levels (143.3 mg / dl versus 137 mg / dl, p > 0.00), levels of 7.09% HA1c to 7.02%, p < 0.003, total cholesterol levels of 191.4 mg / dl to 181.5, levels of LDL cholesterol from 114.7 to 105.5, as well as the baseline triglyceride levels 144.5 mg / dl to 138.8 was observed along the folloup period of 3 years. Featuring an elevation of HDL cholesterol levels significantly 49.2 verus 49.9 mg / dl. The incidences of diabetic complications along the follow-up was a low coronary heart disease 6.2%, peripheral disease 3%, ischemic stroke 2.8%, diabetic foot 11.2%, nephropathy 5.9%, retinopathy 4.5%, and neuropathy 3%. Conclusion The incidence of DM2 in clinical practice along the follow-up in the Community of Madrid is low, and a best control is achieved along the years with a favorable control of glucose, HbA1c, lipid and blood pressure, all cardiovascular risk factors.